These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 1099445

  • 1. Efficacy of 17alpha-hydroxyprogesterone caproate in the prevention of premature labor.
    Johnson JW, Austin KL, Jones GS, Davis GH, King TM.
    N Engl J Med; 1975 Oct 02; 293(14):675-80. PubMed ID: 1099445
    [Abstract] [Full Text] [Related]

  • 2. High-risk prematurity--progestin treatment and steroid studies.
    Johnson JW, Lee PA, Zachary AS, Calhoun S, Migeon CJ.
    Obstet Gynecol; 1979 Oct 02; 54(4):412-8. PubMed ID: 492618
    [Abstract] [Full Text] [Related]

  • 3. 17alpha-hydroxyprogesterone caproate for the prevention of preterm delivery: A cost-effectiveness analysis.
    Odibo AO, Stamilio DM, Macones GA, Polsky D.
    Obstet Gynecol; 2006 Sep 02; 108(3 Pt 1):492-9. PubMed ID: 16946206
    [Abstract] [Full Text] [Related]

  • 4. Efficacy of 17α-hydroxyprogesterone caproate in prevention of preterm delivery.
    Saghafi N, Khadem N, Mohajeri T, Shakeri MT.
    J Obstet Gynaecol Res; 2011 Oct 02; 37(10):1342-5. PubMed ID: 21564406
    [Abstract] [Full Text] [Related]

  • 5. Does progesterone treatment influence risk factors for recurrent preterm delivery?
    Meis PJ, Klebanoff M, Dombrowski MP, Sibai BM, Leindecker S, Moawad AH, Northen A, Iams JD, Varner MW, Caritis SN, O'Sullivan MJ, Miodovnik M, Leveno KJ, Conway D, Wapner RJ, Carpenter M, Mercer B, Ramin SM, Thorp JM, Peaceman AM, Gabbe S.
    Obstet Gynecol; 2005 Sep 02; 106(3):557-61. PubMed ID: 16135587
    [Abstract] [Full Text] [Related]

  • 6. Prevention of premature labor by 17 alpha-hydroxyprogesterone caproate.
    Yemini M, Borenstein R, Dreazen E, Apelman Z, Mogilner BM, Kessler I, Lancet M.
    Am J Obstet Gynecol; 1985 Mar 01; 151(5):574-7. PubMed ID: 3976757
    [Abstract] [Full Text] [Related]

  • 7. Prophylactic use of hydroxyprogesterone caproate in abdominal surgery during pregnancy. A retrospective evaluation.
    Hill LM, Johnson CE, Lee RA.
    Obstet Gynecol; 1975 Sep 01; 46(3):287-90. PubMed ID: 1161231
    [Abstract] [Full Text] [Related]

  • 8. Elective cervical suture in preventing premature delivery in multiple pregnancies.
    Zakut H, Insler V, Serr DM.
    Isr J Med Sci; 1977 May 01; 13(5):488-92. PubMed ID: 873765
    [Abstract] [Full Text] [Related]

  • 9. 17 hydroxyprogesterone for the prevention of preterm delivery.
    Meis PJ, Society for Maternal-Fetal Medicine.
    Obstet Gynecol; 2005 May 01; 105(5 Pt 1):1128-35. PubMed ID: 15863556
    [Abstract] [Full Text] [Related]

  • 10. Outcomes With Cerclage Alone Compared With Cerclage Plus 17α-Hydroxyprogesterone Caproate.
    Stetson B, Hibbard JU, Wilkins I, Leftwich H.
    Obstet Gynecol; 2016 Nov 01; 128(5):983-988. PubMed ID: 27741201
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological use of progesterone and 17-alpha-hydroxyprogesterone caproate in the prevention of preterm delivery.
    Facchinetti F, Vaccaro V.
    Minerva Ginecol; 2009 Oct 01; 61(5):401-9. PubMed ID: 19749671
    [Abstract] [Full Text] [Related]

  • 12. Progestational agents to prevent preterm birth: a meta-analysis of randomized controlled trials.
    Sanchez-Ramos L, Kaunitz AM, Delke I.
    Obstet Gynecol; 2005 Feb 01; 105(2):273-9. PubMed ID: 15684151
    [Abstract] [Full Text] [Related]

  • 13. The effect of 17 alpha-hydroxyprogesterone caproate on pregnancy outcome in an active-duty military population.
    Hauth JC, Gilstrap LC, Brekken AL, Hauth JM.
    Am J Obstet Gynecol; 1983 May 15; 146(2):187-90. PubMed ID: 6682631
    [Abstract] [Full Text] [Related]

  • 14. Inefficacy of 17 alpha-hydroxyprogesterone caproate in the prevention of prematurity in twin pregnancy.
    Hartikainen-Sorri AL, Kauppila A, Tuimala R.
    Obstet Gynecol; 1980 Dec 15; 56(6):692-5. PubMed ID: 7443111
    [Abstract] [Full Text] [Related]

  • 15. The risk for preterm labor in women receiving 17 alpha-hydroxyprogesterone caproate prophylaxis for preterm birth prevention.
    Joy S, Rhea DJ, Istwan NB, Desch CN, Stanziano G.
    Am J Perinatol; 2010 Apr 15; 27(4):343-8. PubMed ID: 20013580
    [Abstract] [Full Text] [Related]

  • 16. Prophylaxis with 17 alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery: does gestational age at initiation of treatment matter?
    How HY, Barton JR, Istwan NB, Rhea DJ, Stanziano GJ.
    Am J Obstet Gynecol; 2007 Sep 15; 197(3):260.e1-4. PubMed ID: 17826411
    [Abstract] [Full Text] [Related]

  • 17. [Results of prophylactic oral long term tocolysis and cerclage for the prolongation of twin pregnancy (a multi-center study)].
    Endl J, Baumgarten K.
    Z Geburtshilfe Perinatol; 1982 Sep 15; 186(6):319-25. PubMed ID: 6761988
    [No Abstract] [Full Text] [Related]

  • 18. [Hormonal studies and clinical observations in patients with threatening abortion or premature birth, respectively treated with depot-17-alpha-hydroxyprogesterone-caproate].
    Tóth F, Kónya Z.
    Z Geburtshilfe Gynakol; 1971 Oct 15; 175(2):168-75. PubMed ID: 5118523
    [No Abstract] [Full Text] [Related]

  • 19. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D.
    Toxic Rep Ser; 1995 Apr 15; 30():1-G5. PubMed ID: 12209194
    [Abstract] [Full Text] [Related]

  • 20. Ritodrine hydrochloride: a betamimetic agent for use in preterm labor. II. Evidence of efficacy.
    Merkatz IR, Peter JB, Barden TP.
    Obstet Gynecol; 1980 Jul 15; 56(1):7-12. PubMed ID: 6992003
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.